Federal Funding
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK.
The National Cancer Institute (NCI) is sponsoring a new Cancer Systems Biology Consortium (CSBC) that includes U54 CSBC Research Centers (RFA-CA-15-014), a U24 CSBC Coordinating Center (RFA-CA-15-015) and, through this FOA, well-defined, discrete and circumscribed Research Projects addressing
This Funding Opportunity Announcement (FOA) will support the development and characterization of state-of-the-art biomimetic tissue-engineered technologies for cancer research.
The purpose of this Funding Opportunity Announcement (FOA) is to: (i) invite researchers to submit collaborative research project (U01) applications to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk and cancer diagnosis aimed at integrating multi-
This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward the discovery and preclinical testing of novel compounds for the prevention and treatment of nervous system disorders.
This Funding Opportunity Announcement (FOA) encourages applications to conduct ancillary studies to the NIDDK Intestinal Stem Cell Consortium (ISCC). Studies will make use of consortium collaborations, techniques or resources to accelerate research into intestinal stem cells.
This Funding Opportunity Announcement (FOA) encourages research grant applications
The Stimulating Hematology Investigation: New Endeavors (SHINE) program is intended to promote innovative, high quality hematology research relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
The purpose of this funding opportunity announcement is to encourage applications on biomarker discovery that utilize metabolomics approaches to advance the understanding, assessment and management of symptoms.
The purpose of this funding opportunity announcement is to encourage applications on biomarker discovery that utilize metabolomics approaches to advance the understanding, assessment and management of symptoms.